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Background
The aim of this study was to show the clinical charac-
teristics and treatment of Hereditary Angioedema
(HAE) in a tertiary center from Curitiba, south of Brazil.
Methods
A cross-sectional study reviewing records of patients in
the Hospital de Clínicas, Federal University of Paraná.
We analised the clinical characteristics, laboratory tests
and treatment of patients with HAE.
Results
Forty two patients, male (45%), age mean 27.1±16.9
years. Symptoms started at median age 14 years (range
1 to 58ys.). Thirty seven (86%) had familial history of
HAE. They had a median of 2 episodes/mo (range 0.2
to 30) lasting 3±1.7 days/episode. Edema of limbs, face,
genital and laryngeal, abdominal pain, diarrhea and
vomiting were seen in 73.8%, 52.4%, 23.8%, 17%, 81%,
24% and 38.1%, respectively. Twenty four (57%) had low
C4 level, mean serum level of C4=12.7±10.6 mg/dL; 26
(62%) had low levels of C1 esterase inhibitor, 4 (9.5%)
had low functional C1 esterase inhibitor and 12 (28.6%)
had C1q deficiency and 3 (7.1%) had HAE type III con-
firmed. Fifteen (28.9%) were treated with Danazol
175±134 mg/day, 15 (28.9%) were using tranexamic acid
as needed. No patient had Icatibant access.
Conclusions
HAE is a difficult to control disease. Patients needs to
have a facilitated access to newer therapies to control
their symptoms and reduce the adverse events of
Danazol.
Published: 8 April 2015
doi:10.1186/1939-4551-8-S1-A190
Cite this article as: Rosario et al.: Laryngeal edema is common in HAE
and demands preventive measures. World Allergy Organization Journal
2015 8(Suppl 1):A190.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Federal University of Paraná, Brazil
Rosario et al. World Allergy Organization Journal 2015, 8(Suppl 1):A190
http://www.waojournal.org/content/8/S1/A190
© 2015 Rosario et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
